Related by context. All words. (Click for frequent words.) 76 test OGTT 75 OGTT 72 fasting blood glucose 71 fasting plasma glucose 67 hemoglobin A1c HbA1c 67 glucose tolerance test 66 glycosylated hemoglobin 66 fasting glucose 66 hemoglobin A1C 66 urine albumin 65 impaired fasting glucose 65 plasma glucose 65 fasting insulin 65 urinary albumin 65 alanine aminotransferase ALT 64 fructosamine 64 fasting glucose levels 64 microalbuminuria 64 fasting plasma glucose FPG 64 microalbumin 64 lispro 63 creatinine levels 63 glycated hemoglobin 63 estimated glomerular filtration 63 calculated creatinine clearance 63 glycated hemoglobin HbA1c 63 liver biopsies 62 alanine aminotransferase 62 MetS 62 serum potassium 62 creatinine ratio 62 cTnT 62 specific antigen PSA 62 hemoglobin A1c 62 glycosylated hemoglobin HbA1c 62 thyroid stimulating hormone 62 HbA1C 62 nonfasting 62 glomerular filtration rate 62 carotid intima media 61 creatinine clearance 61 serum concentrations 61 glycated hemoglobin levels 61 apnea hypopnea index 61 HbA1c levels 61 macroalbuminuria 61 serum PSA 61 D dimer 61 albumin creatinine ratio 61 troponin T 61 skin prick 61 HOMA IR 61 glycemia 61 serum uric acid 60 postprandial glucose 60 elevated ALT 60 HbA 1c 60 HbA1c 60 urinary sodium excretion 60 antibody titer 60 methacholine 60 mmol L 60 methacholine challenge 60 unpaired t 60 digital rectal examination 60 albumin excretion 60 flow mediated dilation 60 Hb A1C 60 Prostate Specific Antigen PSA 60 fasting triglycerides 60 aspartate aminotransferase AST 60 Index CDAI 60 overnight polysomnography 59 serum phosphorous 59 fasting serum 59 DEXA scan 59 creatine kinase 59 Wilcoxon rank sum 59 fasting plasma 59 plasma glucose levels 59 lowest tertile 59 oral antidiabetic medication 59 NIHSS 59 urine cytology 59 insulin detemir 59 hemoglobin A1c levels 59 estimated GFR 59 Oral Glucose Tolerance 59 glomerular filtration 59 DAS# [002] 59 impaired glucose tolerance 59 serum creatinine 59 FEV1 59 hs CRP 59 DCCT 59 ANOVA 59 serum IGF 59 baseline HbA1c 59 logistic regression analysis 59 μg kg 59 iPTH 59 Fasting glucose 59 nondiabetic 59 glucose insulin 59 Hemoglobin A1c 59 univariate analysis 58 univariate 58 eGFR 58 serum ferritin 58 abdominal circumference 58 hsCRP levels 58 #mmHg [001] 58 posttest 58 Crohn Disease Activity 58 erythrocyte sedimentation rate 58 nondiabetic patients 58 coronary arteriography 58 glulisine 58 apolipoprotein B 58 urine dipstick 58 elevated triglycerides 58 -#.# ± [002] 58 #mg/day [001] 58 euglycemic hyperinsulinemic clamp 58 triglyceride concentrations 58 ADAS Cog 58 nmol L 58 biphasic insulin aspart 58 posttransplant 58 #mg/day [002] 58 creatinine 58 primary hypercholesterolemia 58 Response Evaluation Criteria 58 serum glucose 58 #.#mmol L [002] 58 intact parathyroid hormone 58 virologic failure 58 serum cortisol 58 serum testosterone 58 glucose tolerance 58 NPH insulin 58 Hemoglobin A1C 58 mCi 58 PSA nadir 58 overt nephropathy 58 thyroglobulin 58 elevated LDL cholesterol 58 endometrial thickness 58 CC genotype 58 ml kg 58 triacylglycerol 58 -#.# mg dL [002] 58 serum prostate 58 Montgomery Asberg Depression 58 mL/min/#.# m 2 58 spirometry 58 albuminuria 58 μmol L 58 mEq L 57 elevated creatinine 57 multivariate logistic regression 57 fingerstick 57 cTnT levels 57 d dimer 57 postintervention 57 liver histology 57 #ng/ml 57 ng dL 57 euglycemic clamp 57 Multivariate analysis 57 serum leptin 57 nondiabetics 57 Alzheimer Disease Assessment 57 pulmonary arterial 57 salivary cortisol 57 ALT normalization 57 Montgomery Åsberg Depression 57 elevated serum creatinine 57 atherogenic dyslipidemia 57 CARDIA 57 BENICAR HCT 57 thyroxine 57 DAS# CRP 57 cTnI 57 corrected QT interval 57 #.#mmHg 57 Insulin sensitivity 57 umol L 57 endometrial biopsy 57 serum urate 57 insulin lispro 57 hypogonadal 57 C Reactive Protein 57 AST ALT 57 insulin degludec 57 eNO 57 IELT 57 Fasting blood glucose 57 plasma leptin 57 lipid profiles 57 C reactive protein 57 CK MB 57 detectable HCV RNA 57 Apgar scores 57 serum lipid levels 57 A1c 57 HBeAg seroconversion 57 Apidra ® 57 mm Hg diastolic 57 immunohistochemical 57 intima media thickness 57 MADRS score 57 sUA 57 follicle stimulating hormone FSH 57 intraobserver 57 anthropometric measurements 57 exhaled nitric oxide 57 blood glucose concentrations 57 finger prick blood 57 SGPT 57 peripheral blood mononuclear 57 isoprostane 57 mg dl 57 NIH CPSI 57 Fasting plasma glucose 57 CrCl 57 Solid Tumors RECIST 57 Haptoglobin 57 microalbumin test 57 International Prostate Symptom 57 PSADT 57 thyroid stimulating hormone TSH 57 aPTT 57 p = .# [002] 57 abacavir lamivudine 57 mineral density 57 nonfasting triglyceride levels 57 normotensive 57 LDL HDL 57 adenotonsillectomy 57 multiple logistic regression 56 #mmHg [002] 56 nonobese 56 elevated blood glucose 56 hours postdose 56 mg kg dose 56 pg mL 56 mg dL 56 total cholesterol LDL 56 serum insulin 56 fetuin 56 bronchoalveolar lavage 56 activated partial thromboplastin 56 cystatin C 56 mmol l 56 mL kg 56 EDSS score 56 BENICAR 56 Psoriasis Area 56 albumin excretion rate 56 leukocyte count 56 highest tertile 56 spirometric 56 serum bilirubin 56 aspartate aminotransferase 56 #.#ng/ml 56 A1C 56 ug kg 56 rs# [002] 56 serum CRP 56 Hb A1c 56 mU L 56 mucosal healing 56 Subgroup analysis 56 plasma cortisol 56 â ‰ ¥ 56 euthyroid 56 Kruskal Wallis test 56 alkaline phosphatase 56 serum HCV RNA 56 aminotransferases 56 posttreatment 56 urinary albumin excretion 56 insulin glargine 56 UKPDS 56 F FDG PET 56 State Examination MMSE 56 Secondary efficacy endpoints 56 lactate dehydrogenase LDH 56 Glomerular filtration rate 56 dehydroepiandrosterone sulfate 56 lipid profile 56 apolipoproteins 56 IU mL 56 Brief Psychiatric 56 fasting triglyceride levels 56 dietary questionnaires 56 hyperinsulinemic euglycemic clamp 56 Primary endpoints 56 1c HbA 1c 56 Alanine 56 NHANES III 56 serum sodium 56 advanced neoplasia 56 peak VO2 56 urinary N telopeptide 56 genotypic resistance 56 cardiac troponin T 56 Scale EDSS 56 adiponectin concentrations 56 blood urea nitrogen 56 univariate analyzes 56 QTc 56 QRS duration 56 mg/m2 dose 56 ìg 56 pelvic ultrasound 56 virologic response 56 AUC0 56 IPSS 56 LANTUS R 56 pCR 56 Visual Analogue Scale VAS 56 virological response 56 #.#mg/dL 56 coronary stenosis 56 glucose concentrations 56 Stop Hypertension diet 56 QIDS SR 56 preintervention 56 lactate dehydrogenase 56 Negative Syndrome 56 % Confidence Interval 56 serum TSH 56 HAQ DI 56 NYHA functional class 56 proteinuria 56 interrater reliability 56 nmol 56 biochemical relapse 56 dose titration 56 asymptomatic carotid stenosis 56 tipranavir r 56 semiquantitative 56 carotid artery intima media 56 colorectal adenoma 56 ritonavir boosted 55 fasting lipid 55 Prostate Specific Antigen 55 LDL particle 55 MBq 55 Logistic regression analysis 55 serum aminotransferase levels 55 immunostaining 55 Kaplan Meier analysis 55 transferrin saturation 55 #mg/dL [001] 55 serum selenium 55 MMSE score 55 plasma lipids 55 left ventricular systolic 55 Ejection Fraction 55 depressive symptomatology 55 dapagliflozin plus 55 hsCRP 55 lipoprotein levels 55 insulin glulisine 55 serum calcium 55 biochemical recurrence 55 multivariate analyzes 55 serum phosphate 55 APTIVUS r 55 tPSA 55 hemoglobin Hb 55 tHcy 55 β blockers 55 NIHSS score 55 urodynamic 55 mmol 55 intestinal biopsy 55 subclinical hypothyroidism 55 elevated fasting glucose 55 T2DM 55 LVEF 55 polysomnogram 55 endothelial function 55 lumbar spine BMD 55 ELISpot 55 clinically meaningful improvement 55 cortisol concentrations 55 CLA supplementation 55 fructose intolerance 55 advanced adenoma 55 Neuropsychiatric Inventory NPI 55 symptomatic VTE 55 thyrotropin 55 platelet reactivity 55 serum lipid 55 #mg/dl 55 lactose malabsorption 55 #mg doses [002] 55 adjunctive placebo 55 adenoma 55 ng mL 55 QT intervals 55 hydroxyvitamin D levels 55 glycated albumin 55 colesevelam HCl 55 HbA 1c levels 55 hydroxy vitamin D 55 -#.# ± [001] 55 A1C levels 55 Cmax 55 tertile 55 Health Assessment Questionnaire 55 concomitant medications 55 submaximal exercise 55 peptide BNP 55 statin monotherapy 55 HCV antibody 55 tirofiban 55 diabetes mellitus DM 55 sustained virologic response 55 mg kg hr 55 budesonide pMDI 55 cardiac troponin 55 timepoints 55 irbesartan 55 HBeAg negative patients 55 walk distance 6MWD 55 intramuscular dose 55 severe neutropenia 55 YMRS 55 postdose 55 CI -#.# 55 Stop Hypertension DASH diet 55 % CI #.#-#.# [003] 55 active comparator 55 triglyceride concentration 55 serum urate levels 55 A1c levels 55 NSTE ACS 55 airway responsiveness 55 postprandial insulin 55 liver biopsy 55 HSCT 55 advanced adenomas 55 mmHg diastolic 55 Unified Parkinson Disease 55 baseline serum creatinine 55 N telopeptide 55 plasma triglycerides 55 RECIST Response Evaluation Criteria 55 gallstone disease 55 conditional logistic regression 55 serum phosphorus 55 postprandial glucose PPG 55 metabolic parameters 55 insulin aspart 55 6MWT 55 lipid levels 55 moderate renal impairment 55 seroprotection 55 sodium excretion 55 HbA1C levels 55 glargine 54 hypocaloric diet 54 ACR Pedi 54 carotid IMT 54 NGAL 54 antigen PSA levels 54 prospectively randomized 54 cardiorespiratory fitness 54 ADAS cog 54 culture supernatants 54 neuropsychological tests 54 μg dL 54 inhibin B 54 mg TID 54 Endothelial function 54 HDL triglycerides 54 radioimmunoassay 54 pre eclamptic 54 micrograms mcg 54 Solid Tumors criteria 54 mmol L. 54 plasma folate 54 % CI #.#-#.# [006] 54 GH deficiency 54 pharmacokinetic PK profile 54 tertiles 54 echocardiographic 54 detemir 54 periprocedural 54 fibrinolysis 54 VCUG 54 mmHg systolic 54 KOMBIGLYZE XR 54 abnormal cytology 54 triiodothyronine 54 ≥ 54 diuretic chlorthalidone 54 serum creatinine levels 54 aminotransferase ALT 54 retest reliability 54 CCyR 54 QT QTc 54 immunoglobulin G 54 Subgroup analyzes 54 postprandial blood glucose 54 HDL LDL 54 lactulose 54 severe renal impairment 54 Rating Scale MADRS 54 preoperative PSA 54 IDDM 54 Index CDAI score 54 logistic regression analyzes 54 #.#mmol L [001] 54 bronchial hyperresponsiveness 54 upper endoscopy 54 transaminase 54 spontaneous bowel movements 54 thickness CIMT 54 IgA deficiency 54 variance ANOVA 54 nmol liter 54 dose clopidogrel 54 perfusion MRI 54 trough FEV1 54 Bonferroni correction 54 flexible sigmoidoscopy 54 pmol L 54 coronary revascularization 54 prolonged QT interval 54 multivariable analysis 54 dobutamine 54 systolic dysfunction 54 Solid Tumours 54 transaminases 54 gastric emptying 54 diabetic rats 54 NovoLog ® Mix 54 logistic regression 54 D Dimer 54 PCWP 54 plasma lipid 54 hematological parameters 54 min -1 54 poor metabolizers 54 undetectable HCV RNA 54 Thrombolysis 54 nonfatal MI 54 Pearson correlation coefficient 54 left ventricular hypertrophy 54 serum calcium levels 54 bortezomib refractory 54 VO2max 54 #μg [001] 54 maternal serum 54 Fecal occult blood 54 elevated transaminases 54 categorical variables 54 protein excretion 54 IgG antibody 54 pg ml 54 primary percutaneous coronary 54 GnRH agonist 54 Score IPSS 54 serum cholesterol 54 QTcF 54 primary aldosteronism 54 systolic blood pressure 54 pulmonary artery pressure 54 ACR# response 54 Skin sterol 54 bolus dose 54 serum albumin 54 nonpregnant women 54 lipid lowering therapy 54 PREZISTA r 54 paricalcitol 54 rheumatoid factor 54 Regression analyzes 54 confidence intervals CIs 54 chest radiographs 54 urinary calcium 54 statistical significance p 54 mealtime insulin 54 log# copies mL 54 subscore 54 maximal aerobic capacity 54 follicular phase 54 NATRECOR R 54 binary logistic regression 54 ± SD 54 inhibin 54 esophagogastroduodenoscopy 54 multivariable Cox 54 QTc prolongation 54 myocardial uptake 54 triglyceride levels 54 P = .# 54 fraction LVEF 54 ng ml 54 multivariate Cox 54 ABC/3TC 54 lipid parameters 54 mm Hg systolic 54 T1DM 54 glimepiride 54 IQR 54 estrogen receptor ER 54 apolipoprotein A1 54 peginterferon 54 Univariate 54 residual platelet reactivity 54 microg 54 confidence interval #.#-#.# 54 glycosylated hemoglobin levels 54 prothrombin 54 indirect calorimetry 54 OADs 54 chemoradiation therapy 53 Interrater reliability 53 CIMZIA TM 53 preoperatively 53 HER2 expression 53 K ras mutations 53 iloprost 53 left ventricular dysfunction 53 SGOT 53 liver steatosis 53 coronary artery calcification 53 mcg kg 53 per deciliter mg 53 ertapenem 53 LEXIVA r 53 CD4 + cell 53 Hamilton Anxiety Scale 53 QTc intervals 53 nonobstructive CAD 53 BMI waist circumference 53 serum ALT 53 Secondary endpoints included 53 Logistic regression 53 #mg dose [003] 53 Inhibin B 53 antihypertensive medications 53 Microalbuminuria 53 BMI ≥ 53 serum IgE 53 SHBG 53 eosinophil count 53 #.#/#.# mmHg [001] 53 Hemoglobin A1c HbA1c 53 Hazard Ratio HR 53 PaO 2 53 serum vitamin D 53 HBsAg 53 serum triglycerides 53 postoperative complication 53 urine NGAL 53 neutrophil counts 53 USPSTF recommends 53 mU 53 Serum concentrations 53 eptifibatide 53 hypoglycemic episodes 53 telomere lengths 53 c reactive protein 53 VKORC1 53 ankle brachial index 53 guaiac 53 cefotaxime 53 SHBG levels 53 grade cervical intraepithelial 53 metformin sulphonylurea 53 Lp PLA 2 53 hemodynamic variables 53 serum HBV DNA 53 Disease Activity 53 FFNS 53 β blocker 53 Cotinine 53 flutamide 53 chi squared 53 #mg/kg [002] 53 Multivariate analyzes 53 prospectively defined 53 ml min 53 = #.#-#.# 53 inotropic agents 53 Wistar rats 53 metabolite concentrations 53 adenoma recurrence 53 Immunohistochemical analysis 53 + PH# 53 serum triglyceride 53 exhaled NO 53 ABCB1 53 benazepril 53 peak expiratory flow 53 pramlintide 53 Prostate specific antigen 53 luteinising hormone LH 53 #mg/dL [002] 53 antihypertensive therapy 53 Secondary endpoints include 53 Insulin PH# 53 transcranial Doppler ultrasound 53 glucose lowering 53 State Exam MMSE 53 serum estradiol 53 coronary calcification 53 intravenous bolus 53 μg liter 53 procalcitonin 53 atorvastatin #mg 53 amoxicillin clavulanate 53 adiponectin levels 53 rs# [003] 53 noninferiority 53 DAS# scores 53 mean baseline HbA1c 53 total cholesterol triglycerides 53 cholesterol LDL C 53 pretest probability 53 PERMP 53 peginterferon alfa 2b 53 arterial stiffness 53 HBeAg positive 53 estrogen metabolites 53 postprocedure 53 Cardiorespiratory fitness 53 polysomnography PSG 53 B7 H3 53 UGT#A# * 53 hypoglycemic events 53 clomipramine 53 sub maximal 53 hydroxyvitamin D 53 qualitative serum 53 systolic BP 53 osteopenic 53 overt hypothyroidism 53 hypertensives 53 rs# [004] 53 anti JCV antibodies 53 hyperphenylalaninemia HPA due 53 PCa 53 induced sputum 53 AVODART 53 mineral density BMD 53 subclinical hyperthyroidism 53 serum triglyceride levels 53 tolvaptan 53 hemoglobin hematocrit 53 sensitivity specificity 53 isocaloric 53 Liver biopsies 53 plasma renin activity 53 fructose diet 53 pelvic lymphadenectomy 53 ABPM 53 HBeAg 53 undetectable HBV DNA 53 uM 53 neutrophil count 53 rFSH 53 -#.# log# copies mL 53 mg QD 53 lipid abnormalities 53 Serum creatinine 53 achieved ACR# 53 abdominal ultrasound 53 Scale cognitive subscale 53 mIU L 53 blood lactate 53 #OHD levels 53 IV bolus 53 Univariate analysis 53 mg qd 53 plasma adiponectin 53 multivariable logistic regression 53 χ 53 transvaginal ultrasound 53 HIV RNA 53 blood glucose levels 53 hip BMD 53 vecuronium 53 aminotransferase levels 53 severe exacerbations 53 insulin sensitivity 53 electrocardiogram EKG 53 ng dl 53 mean serum phosphorus 53 onset diabetes mellitus 53 maximal oxygen 53 CIN2 + 53 left ventricular diastolic 53 serum magnesium 53 glucose intolerant 53 achieved statistical significance 53 Hematocrit 53 coronary angiography 53 DEXA scans 53 interleukin IL -6 53 test FOBT 53 polycystic ovary syndrome PCOS 53 tumor histology 53 epithelial ovarian cancer 53 oral antidiabetic medications 53 LPV r 53 unfractionated heparin 53 anovulatory 53 steroid dexamethasone 53 colorectal neoplasia 53 stone formers 53 CANCIDAS 53 sd = 53 diagnostic angiography 53 APACHE II 53 anthropometric measures 53 HCV RNA 53 #.#g/day 53 PON1 enzyme 53 timepoint 53 Lp PLA2 53 troponin 53 oocytes retrieved 53 KRAS mutation 53 mild renal insufficiency 53 airway hyperresponsiveness 53 inotropic 52 metabolically healthy 52 hyperglycaemia 52 coronary artery calcium 52 waist circumference 52 oral antidiabetes 52 handgrip strength 52 ARB telmisartan 52 TEAEs 52 lymphocytosis 52 mediated dilation 52 lymphocyte count 52 deoxy 52 CK # plasma concentrations 52 FDG uptake 52 mU liter 52 pharmacokinetics PK 52 IL#B 52 Low density lipoprotein 52 pulmonary function 52 brachial artery 52 nomogram 52 paraprotein 52 XIENCE V PROMUS Stent 52 recurrent VTE 52 lispro alone 52 ACTOplus met 52 diastolic blood pressures 52 Liver biopsy 52 #.#mg/kg [001] 52 Severity Index PASI 52 Acetate Rectal Suppositories 52 ejection fraction 52 serum folate 52 pneumonectomy 52 interquartile range 52 fFN 52 EQ 5D 52 alanine transaminase 52 intramuscularly 52 Cystatin C 52 transcranial Doppler 52 transaminase elevations 52 MULTAQ 52 aminotransferase 52 μg d 52 tuberculin skin testing 52 biopsy Gleason 52 TURBT 52 thiazide diuretics 52 linoleic acid LA 52 mcg BID 52 heel lance 52 brachial artery flow 52 orchiectomy 52 AGHD 52 desvenlafaxine succinate 52 endoscopic remission 52 REYATAZ r arm 52 bioelectrical impedance 52 logistic regression model 52 ascending doses 52 elevated triglyceride levels 52 crossclamp 52 elevated CRP 52 conventional cytology 52 adjunctive ABILIFY 52 ADCS CGIC 52 mg d 52 ejection fractions 52 nanograms milliliter 52 IFN α 52 % CI #.#-#.# [007] 52 urinary excretion 52 abnormal lipid 52 plasma creatinine 52 infliximab monotherapy 52 serum lactate 52 IU ml 52 pressure monitoring ABPM 52 heterozygotes 52 oral prednisone 52 mg kg Hematide 52 intraclass correlation coefficients 52 nelfinavir 52 glucose intolerance 52 serum lipids 52 antigen PSA 52 hypokalemia 52 fluvastatin 52 ALT elevations 52 nonsignificant 52 Non inferiority 52 #q# deletion syndrome 52 6MWD 52 osmolality 52 amnestic mild cognitive impairment 52 abdominal adiposity 52 dietary carbohydrate 52 MADRS 52 C telopeptide 52 corticosteroid dose 52 lopinavir r arm 52 oxygen desaturation 52 gliclazide 52 polyp recurrence 52 GSTP1 52 Tasigna prolongs 52 Corus CAD 52 Rh factor 52 EQUATE OB 52 basal insulin 52 hemodilution 52 Prehypertension 52 NMIBC 52 HDL Cholesterol 52 plasma HCV RNA 52 kidney allograft 52 FOLFOX4 52 rosuvastatin #mg 52 dichotomous variables 52 Folfox 52 acute STEMI 52 coronary calcium 52 cells uL 52 Triglyceride levels 52 Seattle Angina Questionnaire 52 urinary oxalate 52 immunochemical 52 Symptom severity 52 maximal treadmill 52 TAXUS p value 52 UACR 52 methotrexate monotherapy 52 % CI #.#-#.# [004] 52 alteplase 52 HBeAg negative 52 NT proBNP 52 statistically nonsignificant 52 mRNA expression 52 evaluable subjects 52 inactive placebo 52 VO2 max 52 definite stent thrombosis 52 histologic 52 elevated TSH 52 Sprague Dawley rats 52 WOMAC pain 52 AlloMap 52 total cholesterol HDL 52 specific IgE 52 adenomatous polyps 52 nmol l 52 hypogonadal men 52 Naive Patients 52 diastolic BP 52 hematopoietic cancers 52 peginterferon alfa 2a 52 postprandial hyperglycemia 52 Likert scale 52 elevated troponin 52 diastolic hypertension 52 HBV DNA levels 52 haptoglobin 52 baseline A1C